New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
11:51 EDTAKAM, ISRG, CMG, SNDK, AZNOptions with increasing implied volatility: AKAM ISRG CMG SNDK AZN
News For AKAM;ISRG;CMG;SNDK;AZN From The Last 14 Days
Check below for free stories on AKAM;ISRG;CMG;SNDK;AZN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 10, 2014
17:36 EDTCMGPenn State Chipotle closed after workers quit, The Daily Collegian says
Subscribe for More Information
15:21 EDTAZNAstraZeneca has a conference call hosted by JPMorgan
Subscribe for More Information
08:42 EDTCMGChipotle price target raised to $775 from $700 at Oppenheimer
Subscribe for More Information
September 9, 2014
20:00 EDTAKAMAkamai to benefit in Q3, Q4 from iOS 8 release, says JPMorgan
Subscribe for More Information
10:35 EDTCMGGundlach says Chipotle shares 'horribly' overvalued
DoubleLine Capital's Jeff Gundlach is speaking on CNBC.
05:22 EDTSNDKToshiba, SanDisk start construction of Fab 2 facility at Yokkaichi, Japan
Subscribe for More Information
September 8, 2014
14:13 EDTAZNConnecticut AG tells FDA to speed up generic Nexium
A news release from the Connecticut Attorney General George Jepsen, dated September 4, says: In comments to a Citizen Petition filed with the FDA, Attorney General George Jepsen called on the federal agency to expeditiously end several years of delays preventing the sale of a generic form of the drug esomeprazole magnesium , esomeprazole, currently marketed under the brand name Nexium. Nexium is the second highest-selling pharmaceutical drug in the United States, and delays in approving generic versions have cost consumers and government healthcare payers billions of dollars. In his comments, Attorney General Jepsen alleges that an agreement between drug manufacturers Ranbaxy (RBXLY) and AstraZeneca Pharmaceuticals (AZN), Nexiumís brand-name manufacturer, has prevented other drug-makers from launching a generic version of the drug, ultimately harming all consumers by artificially inflating prices. Ranbaxy was first-to-file with the FDA for approval of a generic form of Nexium. AstraZeneca sued Ranbaxy for patent infringement, and the dispute was settled by an agreement that provided financial incentives for Ranbaxy to delay entry of its generic into the consumer market. Reference Link
10:06 EDTSNDKOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AIG (AIG) initiated with a Buy at Citigroup... Agilent (A) initiated with an Equal Weight at Morgan Stanley... Altisource Residential (RESI) initiated with a Neutral at JPMorgan... AngloGold (AU) initiated with an Overweight at JPMorgan... Arista Networks (ANET) initiated with an Outperform at FBN Securities... C1 Financial (BNK) initiated with a Buy at Wunderlich... Cherokee (CHKE) initiated with a Buy at Roth Capital... ContraFect (CFRXU) initiated with a Buy at Maxim... DRDGOLD (DRD) initiated with an Underweight at JPMorgan... Enable Midstream (ENBL) initiated with an Equal Weight at Morgan Stanley... Enservco (ENSV) initiated with an Outperform at Northland... GoPro (GPRO) initiated with an Outperform at FBN Securities... Gold Fields (GFI) initiated with an Overweight at JPMorgan... Gulfport Energy (GPOR) initiated with an Equal Weight at Morgan Stanley... Harmony Gold (HMY) initiated with a Neutral at JPMorgan... Illumina (ILMN) initiated with an Equal Weight at Morgan Stanley... LINN Energy (LINE) reinstated with an Outperform at Credit Suisse... LinnCo (LNCO) reinstated with an Outperform at Credit Suisse... Randgold (GOLD) initiated with a Neutral at JPMorgan... Rentrak (RENT) initiated with a Buy at Needham... Rice Energy (RICE) initiated with an Accumulate at KLR Group... SanDisk (SNDK) initiated with an Outperform at FBN Securities... Seadrill (SDRL) initiated with a Sell at Canaccord... Tesla (TSLA) initiated with an Outperform at FBN Securities... Thermo Fisher (TMO) initiated with an Overweight at Morgan Stanley... Waters (WAT) initiated with an Underweight at Morgan Stanley... Whiting Petroleum (WLL) initiated with an Equal Weight at Morgan Stanley.
08:08 EDTSNDKSanDisk initiated with an Outperform at FBN Securities
Target $120.
07:02 EDTAZNAstraZeneca announces availability of Bydureon pen 2mg
Subscribe for More Information
September 5, 2014
10:39 EDTAKAMAkamai seen as 'Google of Internet infrastructure' by UBS
Shares of Akamai (AKAM) are advancing after UBS began coverage of the stock with a positive view, calling the company "the Google of Internet Infrastructure." Akamai provides infrastructure for delivering content over the Internet. WHAT'S NEW: UBS analyst Steven Milunovich initiated coverage of Akamai with a Buy rating in a note to investors today. Like Google (GOOG), Akamai relies on sophisticated algorithms, the analyst stated. Increased demand for Internet media delivery could cause the Internet content delivery sector to perform better than expected, Milunovich believes. Akamai's strong reliability is difficult to match, which should enable it to fend off competition in the space, according to the analyst. Moreover, Milunovich is upbeat on the company's new security and cloud initiatives. He set a $70 price target on the shares. OTHERS TO WATCH: Other companies in the Internet content delivery space include Limelight Networks (LLNW) and Level 3 (LVLT). PRICE ACTION: In mid-morning trading, Akamai rose nearly 1% to $60.91.
10:05 EDTAKAMOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Actavis (ACT) initiated with a Buy at ISI Group... Akamai (AKAM) initiated with a Buy at UBS... Alexion (ALXN) initiated with a Buy at SunTrust... Allegion (ALLE) initiated with a Buy at Buckingham... Allergan (AGN) initiated with a Buy at ISI Group... Aviat Networks (AVNW) initiated with a Neutral at H.C. Wainwright... Celgene (CELG) initiated with a Buy at SunTrust... EZCORP (EZPW) initiated with a Hold at Jefferies... Eaton (ETN) initiated with a Neutral at Buckingham... Emerson (EMR) initiated with a Neutral at Buckingham... HMS Holdings (HMSY) initiated with an Overweight at Stephens... Incyte (INCY) initiated with a Buy at SunTrust... Ingersoll-Rand (IR) initiated with a Neutral at Buckingham... Insmed (INSM) initiated with an Outperform at Cowen... Intercept (ICPT) initiated with an Outperform at Cowen... Johnson & Johnson (JNJ) initiated with an Outperform at BMO Capital... Lennox (LII) initiated with a Neutral at Buckingham... Mylan (MYL) initiated with a Hold at ISI Group... Orion Engineered Carbons (OEC) initiated with a Buy at Goldman... Parker-Hannifin (PH) initiated with a Buy at Buckingham... Pentair (PNR) initiated with a Neutral at Buckingham... Pharmacyclics (PCYC) initiated with a Neutral at SunTrust... Rockwell Automation (ROK) initiated with a Neutral at Buckingham... Sabre (SABR) initiated with an Outperform at Oppenheimer... Santander Consumer (SC) initiated with a Buy at Jefferies... Springleaf (LEAF) initiated with a Buy at Jefferies... Susser Petroleum (SUSP) initiated with a Neutral at Credit Suisse... Teva (TEVA) initiated with a Buy at ISI Group... Valeant (VRX) initiated with a Buy at ISI Group... WESCO (WCC) initiated with a Neutral at Buckingham... Watsco (WSO) initiated with a Neutral at Buckingham... Weyerhaeuser (WY) initiated with a Neutral at JPMorgan... World Acceptance (WRLD) initiated with a Hold at Jefferies.
10:05 EDTSNDKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:31 EDTSNDKSanDisk acquisition positive, says Bernstein
After SanDisk bought Fusion-io, Bernstein thinks the deal plugs the gap in the company's Enterprise SSD market and will accelerate its growth in this new market. The firm expects the deal to be dilutive to SanDisk until 3Q15. It keeps an Outperform rating on the shares.
08:01 EDTSNDKSanDisk upgraded at Morgan Stanley
As previously reported, Morgan Stanley upgraded SanDisk to Overweight from Equal Weight. The firm upgraded shares based on valuation and a solid NAND supply/demand balance for 2015-2016.
05:57 EDTSNDKSanDisk upgraded to Overweight from Equal Weight at Morgan Stanley
05:49 EDTAKAMAkamai initiated with a Buy at UBS
UBS started shares of Akamai with a Buy rating, calling the company the "Google of internet infrastructure." The firm thinks Akamai will fend off CDN business competition through its network relationships and global platform. UBS set a $70 price target for the stock.
September 4, 2014
17:15 EDTAZNAstraZeneca granted orphan status for EFGR non-small cell lung cancer treatment
The FDA posted on its website that AstraZeneca has been granted orphan status for its treatment of epidermal growth factor receptor, or EFGR, mutation-positive non-small cell lung cancer. Reference Link
07:23 EDTAZNAstraZeneca called for inversion clamp down as part of defense, WSJ says
Amid its defense against an unsolicited takeover bid from rival Pfizer (PFE), AstraZeneca (AZN) hired advisers with close ties to the Obama administration, who made calls to senior administration officials urging a clamp down on tax inversions, said The Wall Street Journal, citing people familiar with the previously undisclosed calls. Reference Link
06:55 EDTSNDKSanDisk reinstated with a Buy at Deutsche Bank
Deutsche Bank reinstated shares of SanDisk with a Buy rating citing limited NAND supply risk in the next 12 months and the demand pickup from SSDs and smartphones. The firm has a $110 price target for shares.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use